Marlies Peeters

Medicine & Life Sciences

1. T-Lymphocytes 100%
2. c-Mer Tyrosine Kinase 81%
3. Tumor-Infiltrating Lymphocytes 45%
4. dihydroorotate dehydrogenase 45%
5. Neoplasms 43%
6. Tumor Microenvironment 38%
7. Receptor Protein-Tyrosine Kinases 35%
8. Granzymes 34%
9. Death Domain Receptors 33%
10. pyrimidine 33%
11. Oxidative Phosphorylation 29%
12. Cell Cycle Checkpoints 26%
13. Protein-Tyrosine Kinases 24%
14. Cytokines 22%
15. Respiration 22%
16. Immune System 21%
17. Blood Platelets 21%
18. Immunotherapy 17%
19. Cell Proliferation 17%
20. UNC2025 15%
21. Protein S 15%
22. Phosphatidylserines 14%
23. quizartinib 12%
24. Antigen-Presenting Cells 12%
25. Cellular Microenvironment 11%
26. Melanoma 10%
27. Ligands 10%
28. Therapeutics 10%
29. T-Cell Antigen Receptor 9%
30. Oncogenes 8%
31. G2 Phase 7%
32. Immunity 7%
33. Neoplasm Antigens 7%
34. Tumor Necrosis Factor Receptor Superfamily, Member 7 6%
35. Pyrimidines 6%
36. Cell- and Tissue-Based Therapy 6%
37. growth arrest-specific protein 6 6%
38. Cell Survival 5%
39. Small Interfering RNA 5%
40. Uridine 5%
41. Cell Cycle 5%
42. Carcinogenesis 5%
43. Cytostatic Agents 5%